Presentaciones Efficacy and safety of first line ribociclib + letrozole in patients with de novo metastatic disease and late recurrence from (neo) adjuvant therapy in MONALEESA-2 J O’Shaughnessy et al. Descargar póster Correlation of circulating tumor...